17 related articles for article (PubMed ID: 21547347)
1. Gefitinib or lapatinib with foretinib synergistically induce a cytotoxic effect in melanoma cell lines.
Dratkiewicz E; Pietraszek-Gremplewicz K; Simiczyjew A; Mazur AJ; Nowak D
Oncotarget; 2018 Apr; 9(26):18254-18268. PubMed ID: 29719603
[TBL] [Abstract][Full Text] [Related]
2. EGFR in melanoma: clinical significance and potential therapeutic target.
Boone B; Jacobs K; Ferdinande L; Taildeman J; Lambert J; Peeters M; Bracke M; Pauwels P; Brochez L
J Cutan Pathol; 2011 Jun; 38(6):492-502. PubMed ID: 21352258
[TBL] [Abstract][Full Text] [Related]
3. A therapeutic opportunity in melanoma: ErbB4 makes a mark on skin.
Settleman J
Cancer Cell; 2009 Oct; 16(4):278-9. PubMed ID: 19800573
[TBL] [Abstract][Full Text] [Related]
4. Malignant melanoma with monster cells showing massive cyclin D1 amplification.
Pouryazdanparast P; Newman M; Mafee M; Guitart J; Gerami P
Am J Dermatopathol; 2009 Jun; 31(4):402-3. PubMed ID: 19461251
[No Abstract] [Full Text] [Related]
5. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases.
Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU
Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316
[TBL] [Abstract][Full Text] [Related]
6. Mutated ERBB4: a novel drug target in metastatic melanoma?
Kurppa K; Elenius K
Pigment Cell Melanoma Res; 2009 Dec; 22(6):708-10. PubMed ID: 19735458
[No Abstract] [Full Text] [Related]
7. No evidence for ErbB4 gene amplification in malignant melanoma.
Brockhoff G; Bock M; Gantner S; Hafner C
Acta Derm Venereol; 2011 Jun; 91(4):488-90. PubMed ID: 21547347
[No Abstract] [Full Text] [Related]
8. PHGDH amplification and altered glucose metabolism in human melanoma.
Mullarky E; Mattaini KR; Vander Heiden MG; Cantley LC; Locasale JW
Pigment Cell Melanoma Res; 2011 Dec; 24(6):1112-5. PubMed ID: 21981974
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
